GenoClipp Biotechnology

GenoClipp Biotechnology is a China-based biotechnology company specializing in the development of next-generation gene-editing technologies. The company's core platform, GenoClipp™, utilizes proprietary CRISPR-based molecular scissors designed for high precision and efficiency in genomic modifications. GenoClipp provides a range of services including custom cell line engineering, animal model generation, and therapeutic lead discovery for genetic diseases and oncology. By leveraging its unique enzymatic tools, the company aims to overcome the limitations of traditional CRISPR/Cas9 systems, such as off-target effects and delivery constraints. The firm is currently advancing a pipeline of gene-edited cell therapies and in vivo treatments while supporting the broader life sciences industry through its CRO and tool-provider business units.